A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Eli Lilly and Company
- Study ID
- NCT05931367
- Phase
- PHASE3
- Status
- Completed
Conditions
- Obesity
- Osteo Arthritis Knee
- Overweight
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Retatrutide — DRUGAdministered SC
- Placebo — DRUGAdministered SC
Study Details
The main purpose of this study is to evaluate the safety and efficacy of retatrutide once-weekly in participants who have obesity or are overweight and have osteoarthritis (OA) of the knee. The study will lasts about 77 weeks.
Key Dates
- Start date
- Aug 1, 2023
- Status verified
- Jan 2026
- Primary completion
- Nov 14, 2025
- Completion
- Nov 14, 2025
Study Design
- Enrollment
- 445 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Retatrutide Dose 1Participants will receive retatrutide subcutaneously (SC).
- Experimental: Retatrutide Dose 2Participants will receive retatrutide SC.
- Placebo Comparator: PlaceboParticipants will receive placebo.
Primary Outcome Measure
Change from Baseline in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Pain Subscale Score [ Time Frame: Baseline, Week 68 ]
Locations (13)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Arizona Research Center | Phoenix | Arizona | 85053 | - |
| Artemis Institute for Clinical Research | San Diego | California | 92103 | - |
| Chase Medical Research, LLC | Waterbury | Connecticut | 06708 | - |
| Suncoast Research Group | Miami | Florida | 33135 | - |
| North Georgia Clinical Research | Woodstock | Georgia | 30189 | - |
| Elite Clinical Trials | Blackfoot | Idaho | 83221 | - |
| Northwestern University | Chicago | Illinois | 60611 | - |
| MedVadis Research Corporation | Waltham | Massachusetts | 02451 | - |
| Great Lakes Research Group, Inc. | Bay City | Michigan | 48706 | - |
| Clinvest Research LLC | Springfield | Missouri | 65807 | - |
| Mercy Family Clinic | Dallas | Texas | 75211 | - |
| Clinical Trials of Texas, Inc. | San Antonio | Texas | 78229 | - |
| Northwest Clinical Research Center | Bellevue | Washington | 98007 | - |
Related coverage on Hipa.ai
- Retatrutide Phase 3 Trial for Obesity and Knee OA Completes Primary Study PeriodRetatrutide · Nov 14, 2025 · ClinicalTrials.gov
Find similar trials in Phoenix, AZ
By condition
By specialty
Related Studies
- Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss TreatmentPHASE2 · Recruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Phoenix, Arizona
- Study to Investigate Genetic Causes of Severe Early Childhood Onset Obesity.Recruiting · Columbia University · Boston, Massachusetts
- Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight MaintenanceRecruiting · University of Michigan · Ann Arbor, Michigan
- Bariatric Embolization of Arteries for the Treatment of Nonalcoholic SteatohepatitisNot Yet Recruiting · Keith Pereira, MD: · St Louis, Missouri